Greenbaum C - Search Results

1

Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.

Long SA, Cerosaletti K, Bollyky PL, Tatum M, Shilling H, Zhang S, Zhang ZY, Pihoker C, Sanda S, Greenbaum C, Buckner JH. Long SA, et al. Among authors: greenbaum c. Diabetes. 2010 Feb;59(2):407-15. doi: 10.2337/db09-0694. Epub 2009 Oct 29. Diabetes. 2010. PMID: 19875613 Free PMC article.

2

Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

Greenbaum CJ, Prigeon RL, D'Alessio DA. Greenbaum CJ, et al. Diabetes. 2002 Apr;51(4):951-7. doi: 10.2337/diabetes.51.4.951. Diabetes. 2002. PMID: 11916912 Clinical Trial.

3

Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.

Greenbaum CJ, Harrison LC; Immunology of Diabetes Society. Greenbaum CJ, et al. Diabetes. 2003 May;52(5):1059-65. doi: 10.2337/diabetes.52.5.1059. Diabetes. 2003. PMID: 12716733 No abstract available.

4

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW. Palmer JP, et al. Among authors: greenbaum cj. Diabetes. 2004 Jan;53(1):250-64. doi: 10.2337/diabetes.53.1.250. Diabetes. 2004. PMID: 14693724

5

The case for intravenous arginine stimulation in lieu of mixed-meal tolerance tests as outcome measure for intervention studies in recent-onset type 1 diabetes.

Greenbaum C, Seidel K, Pihoker C. Greenbaum C, et al. Diabetes Care. 2004 May;27(5):1202-4. doi: 10.2337/diacare.27.5.1202. Diabetes Care. 2004. PMID: 15111546 No abstract available.

6

Autoimmunity to islet proteins in children diagnosed with new-onset diabetes.

Brooks-Worrell BM, Greenbaum CJ, Palmer JP, Pihoker C. Brooks-Worrell BM, et al. Among authors: greenbaum cj. J Clin Endocrinol Metab. 2004 May;89(5):2222-7. doi: 10.1210/jc.2003-031360. J Clin Endocrinol Metab. 2004. PMID: 15126545

7

GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes.

Reijonen H, Mallone R, Heninger AK, Laughlin EM, Kochik SA, Falk B, Kwok WW, Greenbaum C, Nepom GT. Reijonen H, et al. Among authors: greenbaum c. Diabetes. 2004 Aug;53(8):1987-94. doi: 10.2337/diabetes.53.8.1987. Diabetes. 2004. PMID: 15277377

8

Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.

Danke NA, Yang J, Greenbaum C, Kwok WW. Danke NA, et al. Among authors: greenbaum c. J Autoimmun. 2005 Dec;25(4):303-11. doi: 10.1016/j.jaut.2005.08.007. Epub 2005 Oct 24. J Autoimmun. 2005. PMID: 16249070

9

Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects.

Yang J, Danke NA, Berger D, Reichstetter S, Reijonen H, Greenbaum C, Pihoker C, James EA, Kwok WW. Yang J, et al. Among authors: greenbaum c. J Immunol. 2006 Mar 1;176(5):2781-9. doi: 10.4049/jimmunol.176.5.2781. J Immunol. 2006. PMID: 16493034

10

Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes.

Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Rieck M, et al. Among authors: greenbaum c. J Immunol. 2007 Oct 1;179(7):4704-10. doi: 10.4049/jimmunol.179.7.4704. J Immunol. 2007. PMID: 17878369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

335 results

Search Page

Filters